Despite a recent 16% decrease in UnitedHealth Group's share price, its key financial indicators remain decent, such as a 14% return on equity. This suggests potential long-term growth, although its net income growth has been slower than the industry average.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing